Pharmacology, Toxicology and Pharmaceutical Science
Opiate
100%
Opiate Receptor
91%
Buprenorphine
82%
Ligand
64%
Opioid Antagonist
62%
Receptor
61%
Nociceptin
60%
Naltrexone
33%
Rhesus Monkey
30%
Kappa Opiate Receptor
28%
Mu Opiate Receptor Antagonist
27%
Peptide
27%
Analgesic Agent
25%
Partial Agonist
25%
μ-Opioid Receptor
25%
Rat
25%
Opiate Peptide
23%
Disease
23%
Cocaine
22%
Mouse
21%
Binding Site
21%
Kappa Antagonists
19%
Antinociception
19%
Naltrindole
18%
Ether Derivative
18%
Imidazoline
18%
Cannabinoid Receptor Agonist
18%
RGS Protein
18%
Rimcazole
18%
Drug
17%
Kappa Opiate Receptor Agonist
15%
Respiration Depression
15%
Naloxone
14%
Diamorphine
14%
Ethanol
14%
Sulfur 35
12%
Neuropathic Pain
12%
Oripavine
12%
Hot Water
11%
Pruritus
11%
Duragesic
11%
Side Effect
11%
Haplorhini
11%
Spiradoline
10%
Primate
10%
Protein
10%
Opioid Overdose
9%
Morphine
9%
Mu Opiate Receptor Agonist
9%
Delta Opiate Receptor Agonist
9%
Neuroscience
Opiate
41%
Naltrexone
38%
Buprenorphine
29%
Nociceptin
27%
μ-Opioid Receptor
24%
Κ-opioid receptor
21%
Selectivity
19%
Opioid Peptide
18%
Imidazoline
18%
Binding Site
18%
Meta-Analysis
18%
Antidepressant
18%
Kappa Antagonists
17%
Agonist
16%
Drug Abuse
16%
In Vitro
15%
Opioid Antagonist
14%
Receptor Agonists
11%
Behavioral Effect
10%
Eicosanoid Receptor
10%
Behavior (Neuroscience)
10%
Brain
9%
Analeptic
9%
Receptor Affinity
9%
Harman
9%
Naltrindole
9%
Recognition Memory
9%
Alcohol Abuse
9%
Beta Adrenergic Receptor Kinase-2
9%
Imidazoline Receptor
9%
Acetamide
9%
Positron Emission Tomography
9%
Receptor Subtype
9%
Nicotine
9%
Receptor Reserve
9%
Amidines
9%
Monoamine Transporter
9%
Duragesic
9%
Opioid Abuse
9%
Dopamine Receptor D3
9%
Loop Diuretic
9%
Cystic Fibrosis Transmembrane Conductance Regulator
9%
Fentanyl
9%
Creatine Kinase
9%
Creatine Kinase BB
9%
Piperazine
9%
Desipramine
9%
Predator Odor
9%
Receptor
9%
Diuretic
7%
Medicine and Dentistry
Buprenorphine
18%
Opiate Antagonist
18%
Respiration Depression
15%
Partial Agonist
12%
Naltrexone
12%
Receptor
10%
Development
10%
Disease
10%
Abstinence
9%
μ-Opioid Receptor
9%
Nicotine Withdrawal
9%
Peptide Receptor
9%
Partial Agonism
9%
Nociceptin
9%
Hydrocodone
9%
Receptor down Regulation
9%
G Protein Coupled Receptor Kinase
9%
Hypophagia
9%
Diamorphine
9%
Retina S Antigen
9%
Tobacco
9%
Polydrug Abuse
9%
Cocaine
9%
Convulsion
9%
RGS Protein
9%
Drug
9%
Delta Opiate Receptor Agonist
9%
Nuclear Overhauser Effect
9%
Screening
9%
Antidepressant
9%
Desipramine
9%
Opiate
7%
Nicotine Replacement Therapy
6%
Smoking
6%
Craving
6%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
6%
Naloxone
6%
Nociception
6%
Therapeutic Procedure
6%
Morphinone
6%
Oxymorphone
6%
Conditioned Place Preference
5%
κ-Opioid Receptor
5%
